Patient Characteristics
Patient no. | Sex | Age | MBq | Diagnosis | Tracer |
1 | F | 89 | 312 | Breast cancer | 68Ga-FAPI-2 |
2 | M | 55 | 298 | Colorectal cancer | 68Ga-FAPI-2, 18F-FDG |
3 | M | 56 | 256 | Cancer of unknown primary | 68Ga-FAPI-2 |
4 | M | 64 | 336 | Head and neck cancer | 68Ga-FAPI-2 |
5 | M | 66 | 196 | Head and neck cancer | 68Ga-FAPI-2 |
6 | F | 64 | 202 | Head and neck cancer | 68Ga-FAPI-2 |
7 | F | 65 | 178 | Head and neck cancer | 68Ga-FAPI-2 |
8 | M | 59 | 325 | Head and neck cancer | 68Ga-FAPI-2 |
9 | M | 68 | 255 | Head and neck cancer | 68Ga-FAPI-2, 18F-FDG |
10 | M | 70 | 212 | Hepatocellular carcinoma | 68Ga-FAPI-2 |
11 | M | 66 | 308 | Liposarcoma | 68Ga-FAPI-2 |
12 | M | 78 | 222 | Non–small cell lung cancer | 68Ga-FAPI-2, 18F-FDG |
13 | F | 66 | 268 | Non–small cell lung cancer | 68Ga-FAPI-2 |
14 | F | 58 | 126 | Esophagus cancer | 68Ga-FAPI-2, 18F-FDG |
15 | M | 70 | 134 | Esophagus cancer | 68Ga-FAPI-2 |
16 | M | 31 | 307 | Pancreatic cancer | 68Ga-FAPI-2, 18F-FDG |
17 | M | 52 | 167 | Pancreatic cancer | 68Ga-FAPI-2 |
18 | M | 56 | 222 | Pancreatic cancer | 68Ga-FAPI-2 |
19 | F | 73 | 142 | Pancreatic cancer | 68Ga-FAPI-2 |
20 | M | 74 | 122 | Prostate cancer | 68Ga-FAPI-2 |
21 | M | 77 | 318 | Prostate cancer | 68Ga-FAPI-2 |
22 | M | 60 | 285 | Renal cell carcinoma | 68Ga-FAPI-2 |
23 | M | 77 | 225 | Thyroid cancer | 68Ga-FAPI-2, 18F-FDG |
24 | M | 55 | 270 | Thyroid cancer | 68Ga-FAPI-2 |
25 | F | 60 | 238 | Uterus cancer | 68Ga-FAPI-2 |
26 | F | 57 | 263 | Breast cancer | 68Ga-FAPI-4 |
27 | F | 44 | 220 | Colorectal cancer | 68Ga-FAPI-4 |
28 | M | 66 | 286 | Colorectal cancer | 68Ga-FAPI-4 |
29 | M | 55 | 244 | Colorectal cancer | 68Ga-FAPI-4 |
30 | M | 46 | 247 | Cancer of unknown primary | 68Ga-FAPI-4 |
31 | F | 82 | 236 | Head and neck cancer | 68Ga-FAPI-4 |
32 | M | 51 | 263 | Head and neck cancer | 68Ga-FAPI-4 |
33 | M | 84 | 246 | Hepatocellular carcinoma | 68Ga-FAPI-4 |
34 | M | 77 | 299 | Non–small cell lung cancer | 68Ga-FAPI-4 |
35 | F | 58 | 217 | Non–small cell lung cancer | 68Ga-FAPI-4 |
36 | M | 64 | 255 | Non–small cell lung cancer | 68Ga-FAPI-4 |
37 | F | 56 | 250 | Ovarian cancer | 68Ga-FAPI-4 |
38 | F | 67 | 260 | Pancreatic cancer | 68Ga-FAPI-4 |
39 | F | 76 | 243 | Pancreatic cancer | 68Ga-FAPI-4 |
40 | F | 55 | 293 | Pancreatic cancer | 68Ga-FAPI-4 |
41 | M | 52 | 239 | Pancreatic cancer | 68Ga-FAPI-4 |
42 | M | 61 | 198 | Pancreatic cancer | 68Ga-FAPI-4 |
43 | M | 73 | 277 | Pancreatic cancer | 68Ga-FAPI-4 |
44 | M | 57 | 275 | Pancreatic cancer | 68Ga-FAPI-4 |
45 | M | 60 | 237 | Pancreatic cancer | 68Ga-FAPI-4 |
46 | M | 31 | 233 | Pancreatic cancer | 68Ga-FAPI-4 |
47 | M | 71 | 249 | Prostate cancer | 68Ga-FAPI-4 |
48 | M | 64 | 227 | Prostate cancer | 68Ga-FAPI-4 |
49 | M | 72 | 276 | Thyroid cancer | 68Ga-FAPI-4 |
50 | F | 27 | 204 | Thyroid cancer | 68Ga-FAPI-4 |